| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Autonomix Medical, Inc.: Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission | 1 | GlobeNewswire (USA) | ||
| AUTONOMIX MEDICAL Aktie jetzt für 0€ handeln | |||||
| Mo | Autonomix Medical, Inc.: Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award | 1 | GlobeNewswire (USA) | ||
| 05.08. | Morning Market Movers: Gran Tierra Energy, Autonomix Medical, Julong Holding, Shopify See Big Swings | 686 | AFX News | OTTAWA (dpa-AFX) - At 7:55 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 04.08. | US-Patent für Krebstherapie beflügelt Autonomix Medical Aktie | 20 | Investing.com Deutsch | ||
| 04.08. | Autonomix Medical receives patent for nerve-targeting cancer tech | 8 | Investing.com | ||
| 04.08. | Autonomix Medical, Inc.: Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy | 2 | GlobeNewswire (USA) | ||
| 29.07. | Morning Market Movers: Nocera, Autonomix Medical, Vivakor, T3 Defense See Big Swings | 827 | AFX News | BEIJING (dpa-AFX) - At 9:00 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 29.07. | Autonomix Medical (AMIX) Stock Rallies Over 54% After Hours: Here's Why | 21 | Benzinga.com | ||
| 28.07. | Autonomix Medical, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 24.07. | Autonomix Medical, Inc.: Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study | 1 | GlobeNewswire (USA) | ||
| 24.07. | Autonomix reports preclinical data on renal nerve sensing tech | 4 | Investing.com | ||
| 23.07. | Autonomix Medical receives patent for nervous system assessment tech | 2 | Investing.com | ||
| 23.07. | Autonomix Medical, Inc.: Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform | 273 | GlobeNewswire (Europe) | Patent Broadens Intellectual Property Protecting Advanced Autonomic Nervous System Assessment Technologies Designed to Enhance Patient Selection, Treatment Precision and Future Clinical Applications... ► Artikel lesen | |
| 15.07. | Autonomix Medical receives patent for overactive bladder device | 2 | Investing.com | ||
| 15.07. | Autonomix Medical, Inc.: Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform | 432 | GlobeNewswire (Europe) | Newly Issued Patent Expands Company's Neural Sensing Technology Platform into Large Urology Market Affecting Approximately 37 Million Americans THE WOODLANDS, TX, July 15, 2026 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
| 14.07. | Autonomix Medical raises up to $2.6M through warrant inducement | 1 | Seeking Alpha | ||
| 14.07. | Autonomix Medical, Inc.: Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules | 2 | GlobeNewswire (USA) | ||
| 13.07. | Autonomix Medical Slides 11% After Canadian Patent Grant | 2 | RTTNews | ||
| 13.07. | Autonomix Medical, Inc.: Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant | 1 | GlobeNewswire (USA) | ||
| 10.07. | Autonomix Medical, Inc. - 8-K, Current Report | 1 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,820 | -0,70 % | Ihre wichtigsten Termine: Frische Zahlen von Ebay, Eli Lill, Allstate, Infineon, Novo Nordisk, Walt Disney | Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine 06:45 Uhr, Deutschland: Basler... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,030 | -1,41 % | Siemens macht Fortschritte bei Abspaltung von Healthineers | MÜNCHEN (dpa-AFX) - Der Technologiekonzern Siemens kommt bei der geplanten Abspaltung seiner Medizintechniktochter Siemens Healthineers voran. So seien die relevanten steuerlichen Themen mit den Finanzbehörden... ► Artikel lesen | |
| INTUITIVE SURGICAL | 348,20 | +0,17 % | Intuitive Surgical upgraded at Oppenheimer on robotic surgery market growth | ||
| DRAEGERWERK | 111,40 | -0,36 % | Dräger warnt: 'Die Chemieindustrie stirbt leise' | LÜBECK (dpa-AFX) - Der Chef des Lübecker Herstellers von Medizin- und Sicherheitstechnik Drägerwerk, Stefan Dräger, warnt vor dem Niedergang der deutschen Chemieindustrie. "Die Chemieindustrie stirbt... ► Artikel lesen | |
| GERRESHEIMER | 27,220 | -0,51 % | UBS stuft GERRESHEIMER AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Gerresheimer von 12,90 auf 28,50 Euro mehr als verdoppelt und die Aktien folglich von "Sell" auf "Neutral" hochgestuft. Die... ► Artikel lesen | |
| THERMO FISHER | 523,00 | -0,19 % | Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist | The transaction establishes an independent company, with the Microbiology business providing the foundation of a global microbiology diagnostics platform serving the clinical, food safety and... ► Artikel lesen | |
| HIMS & HERS HEALTH | 26,060 | -1,36 % | Hims & Hers: Umsatz hui, Marge pfui - Aktie sackt ab | Der Telehealth-Konzern Hims & Hers hat am Montag nach US-Börsenschluss die Zahlen für das vergangene zweite Quartal vorgelegt. Sowohl umsatz- als auch ergebnisseitig konnten die Amerikaner die Markterwartungen... ► Artikel lesen | |
| OTTOBOCK | 58,90 | 0,00 % | Ottobock im Visier: Shortseller-Panik trotz Insider-Vertrauen | ||
| NUGEN MEDICAL DEVICES | 0,009 | 0,00 % | XFRA 79O: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUGEN MEDICAL DEV.... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,060 | +1,98 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| NETRAMARK | 0,435 | +1,40 % | NetraMark Holdings Inc.: NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness | TORONTO, July 13, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence company transforming clinical... ► Artikel lesen | |
| INSULET | 125,30 | -0,04 % | Insulet Corp. Q2 Profit Advances | WASHINGTON (dpa-AFX) - Insulet Corp. (PODD) released earnings for its second quarter that Increases, from the same period last yearThe company's earnings totaled $95.0 million, or $1.37 per... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,520 | +2,42 % | Can ALHC's Raised 2026 Outlook Offset Heavier Second-Half Spending? | ||
| FRESENIUS MEDICAL CARE | 41,010 | -1,91 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für FMC von 43 auf 39 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Analyst Richard Felton passte seine... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,230 | +6,35 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |